S100A8 Protects Human Primary Alveolar Type II Cells against Injury and Emphysema

Am J Respir Cell Mol Biol. 2019 Mar;60(3):299-307. doi: 10.1165/rcmb.2018-0144OC.

Abstract

Pulmonary emphysema is characterized by alveolar wall destruction, and cigarette smoking is the main risk factor in this disease development. S100A8 is a member of the S100 protein family, with an oxidative stress-related and antiinflammatory role. The mechanisms of human alveolar type II (ATII) cell injury contributing to emphysema pathophysiology are not completely understood. We wanted to determine whether S100A8 can protect ATII cells against injury induced by cigarette smoke and this disease development. We used freshly isolated ATII cells from nonsmoking and smoking organ donors, as well as patients with emphysema to determine S100A8 function. S100A8 protein and mRNA levels were low in individuals with this disease and correlated with its severity as determined by using lung tissue from areas with mild and severe emphysema obtained from the same patient. Its expression negatively correlated with high oxidative stress as observed by 4-hydroxynonenal levels. We also detected decreased serine phosphorylation within S100A8 by PKAα in this disease. This correlated with increased S100A8 ubiquitination by SYVN1. Moreover, we cultured ATII cells isolated from nonsmokers followed by treatment with cigarette smoke extract. We found that this exposure upregulated S100A8 expression. We also confirmed the cytoprotective role of S100A8 against cell injury using gain- and loss-of-function approaches in vitro. S100A8 knockdown sensitized cells to apoptosis induced by cigarette smoke. In contrast, S100A8 overexpression rescued cell injury. Our results suggest that S100A8 protects ATII cells against injury and cigarette smoke-induced emphysema. Targeting S100A8 may provide a potential therapeutic strategy for this disease.

Keywords: alveolar type II cell; apoptosis; cigarette smoke; lung injury; pulmonary emphysema.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • Aged
  • Aldehydes / pharmacology
  • Alveolar Epithelial Cells / drug effects
  • Alveolar Epithelial Cells / metabolism*
  • Apoptosis / drug effects
  • Apoptosis / physiology
  • Calgranulin A / metabolism*
  • Cell Line, Tumor
  • Cigarette Smoking / adverse effects
  • Female
  • Humans
  • Lung / drug effects
  • Lung / metabolism
  • Male
  • Middle Aged
  • Nicotiana / adverse effects
  • Oxidative Stress / drug effects
  • Oxidative Stress / physiology
  • Pulmonary Alveoli / metabolism*
  • Pulmonary Emphysema / metabolism*
  • RNA, Messenger / metabolism
  • Ubiquitin-Protein Ligases / metabolism
  • Up-Regulation / drug effects
  • Up-Regulation / physiology

Substances

  • Aldehydes
  • Calgranulin A
  • RNA, Messenger
  • S100A8 protein, human
  • Ubiquitin-Protein Ligases
  • 4-hydroxy-2-nonenal